Status:

UNKNOWN

Screening for Primary Ciliary Dyskinesia Using Nasal Nitric Oxide

Lead Sponsor:

Ziv Hospital

Conditions:

Primary Ciliary Dyskinesia

Eligibility:

All Genders

Brief Summary

Background: Primary ciliary dyskinesia (PCD) is a rare genetic disease characterised by recurrent respiratory infections and subfertility due to dysfunction of cilia (brushes) of the lining cells. Und...

Eligibility Criteria

Inclusion

  • Voluntary willing to participate

Exclusion

  • Recent URTI
  • Steroids use 2 weeks prior to testing

Key Trial Info

Start Date :

July 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

6000 Patients enrolled

Trial Details

Trial ID

NCT00739817

Start Date

July 1 2010

Last Update

August 18 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pediatric Department, Ziv Medical Center

Safed, Israel

Screening for Primary Ciliary Dyskinesia Using Nasal Nitric Oxide | DecenTrialz